Bristol-Myers Returns Sanofi Drug Rights as Patents Expire

Bristol-Myers Squibb Co. agreed to return rights for the blood thinner Plavix and the hypertension medicine Avapro to its French partner Sanofi now that the drugs are losing patent protection.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.